Cet événement s’adresse aux cliniciens, aux chercheurs et aux professionnels de la santé. Veuillez noter que cet événement se déroule en anglais.
Conférencier
Thomas Lagace, PhD
Scientist & Director
Lipoprotein Receptor Biology Laboratory, UOHI
Associate Professor
Department of Biochemistry, Microbiology and Immunology, Faculty of Medicine, University of Ottawa
Sujet
The evolving story of PCSK9, a secreted protein with roles in cholesterol homeostasis and innate immunity.
PCSK9 promotes degradation of liver LDL receptors, raising blood LDL-cholesterol and related cardiovascular risk. Therapeutic PCSK9 inhibition has revealed an unanticipated role in inflammation and innate immunity.
Endroit
Auditorium Centre (H-2367) et en ligne (Zoom).
Coût
Gratuit.
Inscription
Obligatoire.